Human Immunodeficiency Virus Type 1 Neutralization Measured by Flow Cytometric Quantitation of Single-Round Infection of Primary Human T Cells

There is currently intensive research on the design of novel human immunodeficiency virus type 1 (HIV-1) vaccine immunogens that can elicit potent neutralizing antibodies. A prerequisite for comparing and optimizing these strategies is the ability to precisely measure neutralizing antibody responses...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Mascola, John R., Louder, Mark K., Winter, Christine, Prabhakara, Ranjani, De Rosa, Stephen C., Douek, Daniel C., Hill, Brenna J., Gabuzda, Dana, Roederer, Mario
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2002
Matèries:
Vaccines and Antiviral Agents
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC136170/
https://ncbi.nlm.nih.gov/pubmed/11967298
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.76.10.4810-4821.2002
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars